{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:20Z","timestamp":1787010080541,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1615,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/jto.0b013e3182199be2","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T04:06:06Z","timestamp":1306296366000},"page":"1267-1273","source":"Crossref","is-referenced-by-count":17,"title":["Assessment of Objective Responses Using Volumetric Evaluation in Advanced Thymic Malignancies and Metastatic Non-small Cell Lung Cancer"],"prefix":"10.1016","volume":"6","author":[{"given":"Jeremy","family":"Force","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Dombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3182199be2_bib1","unstructured":"World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva Albany, NY: World Health Organization; sold by WHO Publications Centre USA, WHO offset publication no. 48, 1979. Pp. 45."},{"key":"10.1097\/JTO.0b013e3182199be2_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3182199be2_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1097\/JTO.0b013e3182199be2_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejca.2008.10.027","article-title":"Individual patient data analysis to assess modifications to the RECIST criteria","volume":"45","author":"Bogaerts","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1097\/JTO.0b013e3182199be2_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11864-009-0083-7","article-title":"Treatment of advanced thymoma and thymic carcinoma","volume":"9","author":"Rajan","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"10.1097\/JTO.0b013e3182199be2_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtcvs.2009.03.033","article-title":"Comparison of patterns of relapse in thymic carcinoma and thymoma","volume":"138","author":"Huang","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0b013e3182199be2_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1200\/JCO.2001.19.2.551","article-title":"Comparison of diameter and perimeter methods for tumor volume calculation","volume":"19","author":"Sorensen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3182199be2_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"10.1097\/JTO.0b013e3182199be2_bib9","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.lungcan.2005.03.030","article-title":"CT, RECIST, and malignant pleural mesothelioma","volume":"49","author":"Nowak","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3182199be2_bib10","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa0906085","article-title":"Management of lung nodules detected by volume CT scanning","volume":"361","author":"van Klaveren","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3182199be2_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/JTO.0b013e3181dd0ef1","article-title":"Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans","volume":"5","author":"Liu","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e3182199be2_bib12","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1259\/bjr.73.875.11144795","article-title":"CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size","volume":"73","author":"Sohaib","year":"2000","journal-title":"Br J Radiol"},{"key":"10.1097\/JTO.0b013e3182199be2_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.compmedimag.2004.03.002","article-title":"Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging","volume":"28","author":"Solomon","year":"2004","journal-title":"Comput Med Imaging Graph"},{"key":"10.1097\/JTO.0b013e3182199be2_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-5223(98)70274-0","article-title":"Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma","volume":"115","author":"Pass","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0b013e3182199be2_bib15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1200\/JCO.2009.25.0803","article-title":"Comparison of the prognostic value of assessing tumor diameter versus tumor volume at diagnosis or in response to initial chemotherapy in rhabdomyosarcoma","volume":"28","author":"Ferrari","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3182199be2_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1215\/S1522851705000529","article-title":"Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas","volume":"8","author":"Shah","year":"2006","journal-title":"Neuro Oncol"},{"key":"10.1097\/JTO.0b013e3182199be2_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jnci\/91.6.523","article-title":"Measuring response in solid tumors: unidimensional versus bidimensional measurement","volume":"91","author":"James","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e3182199be2_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejrad.2009.02.002","article-title":"Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma","volume":"74","author":"Ak","year":"2010","journal-title":"Eur J Radiol"},{"issue":"Suppl 15","key":"10.1097\/JTO.0b013e3182199be2_bib19","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1200\/jco.2009.27.15_suppl.7589","article-title":"Phase II study of the histone deacetylase inhibitor belinostat in thymic malignancies","volume":"27","author":"Giaccone","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3182199be2_bib20","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/1078-0432.CCR-10-2331","article-title":"Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small cell lung cancer receiving Sorafenib","volume":"17","author":"Kelly","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415310455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415310455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T21:40:59Z","timestamp":1637703659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415310455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1556086415310455"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3182199be2","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}